City of Hope and Reimagine Care Collaborate to Offer 24/7 Monitoring and Support to Bone Marrow Transplant Patients

Reimagine Care has announced a new partnership with City of Hope, one of the largest cancer research and treatment organizations in the U.S. and a leading research center for life-threatening illnesses. Their collaboration aims to introduce a novel care model for blood stem cell transplant recipients.

This innovative remote patient monitoring program is designed to provide seamless monitoring and proactive symptom management to City of Hope transplant patients upon discharge. It utilizes the BioButtonĀ®, a painless, waterproof, non-invasive device placed on the patient’s chest. Reimagine Care’s team of oncology-trained nurses and advanced practitioners continuously monitor patients’ symptoms and vital signs through the device. If any deterioration in vital signs or distress is detected, the program proactively alerts City of Hope’s medical staff, and Reimagine Care nurses contact and triage the patient.

The BioButton allows for 24/7 monitoring for up to 30 days after an autologous transplant, complementing the already high-quality post-transplant care provided by City of Hope.

“This additional step will help us detect infection early so we can treat it and prevent any serious complications,” says Eileen Smith, M.D., City of Hope’s Francis & Kathleen McNamara Distinguished Chair in Hematology and Hematopoietic Cell Transplantation.

The program will initially launch with eligible myeloma and lymphoma patients who receive an autologous transplant, which utilizes their own stem cells and can cure myeloma and other blood cancers. If successful, the program will be expanded to include more patients, including those who receive allogeneic transplants from donors.

As City of Hope is one of the highest-volume transplant centers in the nation and the largest in California, this program has the potential to significantly enhance real-time communication and the recovery experience for a large number of cancer patients. This partnership represents a significant step towards improving patient care and experience for stem cell transplant recipients, leveraging advanced technology and skilled medical professionals to proactively manage symptoms and enhance recovery from the comfort of patients’ homes.

Read the full press release on BusinessWire.